Preoperative chemotherapy for locally advanced breast carcinoma at Charity Hospital

Cummiskey, Robert D.; Mera, Robertino; Levine, Edward A.
February 1998
American Surgeon;Feb1998, Vol. 64 Issue 2, p103
Academic Journal
Evaluates the Charity Hospital experience with preoperative chemotherapy for locally advanced breast carcinoma in New Orleans, Louisiana. Local treatment for the disease; Categories of patients' responses; Results of the study.


Related Articles

  • Managing Hot Flashes After Breast Cancer. Carpenter, Janet S.; Lambert, Beth; Lockhart, Joan Such // Oncology Nursing Forum;Jan/Feb2000, Vol. 27 Issue 1, p23 

    Focuses on managing hot flashes after breast cancer. Risk factor for hot flashes; Information on the experiences of breast cancer survivors with hot flashes; Treatment options for hot flashes.

  • Should You Take a Drug To Reduce the Risk of Breast Cancer?  // HealthFacts;Apr99, Vol. 24 Issue 4, p5 

    Provides information on the effectiveness of long-term drug therapy in the reduction of breast cancer risks in the United States. Drugs approved by the Food and Drug Administration; Physiological effect of medications; Preventive mechanisms of drugs against breast cancer.

  • Researchers struggle with trials of stem-cell transplants for breast cancer. Stephenson, Joan // JAMA: Journal of the American Medical Association;06/18/97, Vol. 277 Issue 23, p1827 

    Discusses one of the most controversial issues in oncology. Question of whether high-dose chemotherapy followed by a bone marrow or peripheral blood stem-cell transplant offers breast cancer patients better survival odds than conventional treatment; Arguments of proponents and critics; Data on...

  • Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer. Erselcan, T; Kairemo, K J A; Wiklund, T A; Hernberg, M; Blomqvist, C P; Tenhunen, M; Bergh, J; Joensuu, H // British Journal of Cancer;2/15/2000, Vol. 82 Issue 4, p777 

    We compared adjuvant chemotherapy-related myocardial damage by antimyosin scintigraphy in patients who received either nine cycles of FEC (fluorouracil, epirubicin and cyclophosphamide) where the doses of epirubicin and cyclophosphamide were escalated according to the leucocyte nadir (group I,n...

  • Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response. Cameron, D A; Gregory, W M; Bowman, A; Anderson, E D C; Levack, P; Forouhi, P; Leonard, R C F // British Journal of Cancer;7/1/2000, Vol. 83 Issue 1, p98 

    Although clinical response to primary chemotherapy in stage II and III breast cancer is associated with a survival advantage, it is the degree of pathological response in the breast and ipsilateral axilla that best identifies patients with a good long-term outcome. A mathematical model of the...

  • USPSTF Breast Cancer Recommendations. Torrey, Brian // American Family Physician;8/1/2002, Vol. 66 Issue 3, p515 

    Reports on the recommendations released by the U.S. Preventive Services Task Force (USPSTF) on the chemoprevention of breast cancer. Randomized trials reviewed by USPSTF; Women who are considered high risk for breast cancer; Screening guidelines of the USPSTF.

  • Study suggests cognitive dysfunction after chemotherapy.  // HealthFacts;Mar98, Vol. 23 Issue 3, p5 

    Highlights the results of a study of breast cancer patients who were at a high risk of recurrence because they had cancer in four or more lymph nodes. Cognitive deficits due to the stress of having cancer and undergoing treatment; Likelihood of memory and concentration problems; Administration...

  • Side effects expected and experienced by women receiving chemotherapy for breast cancer. Tierney, A.J.; Leonard, R.C.; Taylor, J.; Closs, S.J.; Chetty, U.; Rodger, A. // BMJ: British Medical Journal (International Edition);2/2/91, Vol. 302 Issue 6771, p272 

    Presents a descriptive study of women receiving chemotherapy for breast cancer showing side effects after the treatment in Great Britain. Discrepancies between the side effects; Limitation of knowledge of women about forthcoming treatment; Lists of side effects being told in advance.

  • Is chemotherapy worth its effect on the quality of life? Cerrato, Paul L. // RN;Aug96, Vol. 59 Issue 8, p64 

    Questions the benefits of chemotherapy for breast cancer patients. Effects of the drugs on the quality of life; Study showing patients' view on these effects.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics